Immunofluorescence Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented by Product (Reagents and Kits, Instruments, Consumables & Accessories), by Type, by Application, and by Geography.

Market Snapshot

Immunofluorescence Assay Market Analysis
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.8 %
Immunofluorescence Assay Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The  Immunofluorescence Assay market studied was projected to grow with a CAGR of nearly 5.8% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of large intestine diseases like intestinal cancer, diverticulitis, Crohn’s Disease, ulcerative colitis, and inflammatory bowel disease. According to the American Association for the Advancement of Science (AAAS), the number of people suffering from inflammatory bowel diseases is three times higher than previous estimates, with sufferers also at a higher risk of developing colorectal cancer, affecting over 3 million people across Europe. Furthermore, the growing popularity of drainable ostomy bags and increasing investments in product development is boosting the market growth. However, the gaining popularity of the alternative procedures is  the major drawback of the market growth

Scope of the Report

As per the scope of the report, immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using a fluorescent microscope. This report is segmented by Procedure, by Type, By Application and by Geography.

By Product
Reagents and Kits
Consumables & Accessories
By Type
Indirect Immunofluorescence
Direct Immunofluorescence
By Application
Infectious Diseases
Autoimmune Diseases
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Indirect Immunofluorescence Segment is Dominating the Immunofluorescence Assay Market.

  • The advantages of indirect immunofluorescence are high sensitivity, easy to change signal color based on changing the second antibody which can get commercially. The labeled second antibodies are conveniently obtained. Secondary antibodies are relatively inexpensive compared to primary antibodies. Further cost savings may be made by using the same conjugated secondary antibody to detect different primary antibodies.
  • Apart from the above-mentioned factors, other factors boosting the segment growth are increasing incidence of cancer and infectious diseases where these assays are used to diagnose. According to the World Health Organization, the global cancer burden is expected to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide developed cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Furthermore, the growing investments in research and development programs by the biotechnology companies is boosting the segment growth.
Immunofluorescence Assay Market Growth

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, high prevalence of infectious diseases and cancer in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market. According to National Institutes of Health (NIH),  in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. The statistics prove that the prevalence of cancer is high in the country and this boosts the market growth.

Immunofluorescence Assay Market Share

Competitive Landscape

The  Immunofluorescence Assay market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Thermo Fisher, Inova Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc., Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH, Sino Biological, Danaher.

Table of Contents


    1. 1.1 Study Assumptions and Market Defintion

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Cancer and Other Infectious Diseases

      2. 4.2.2 Growing Investments By Government and Non-government Organizations

    3. 4.3 Market Restraints

      1. 4.3.1 Upsurge of Alternative Tests Which are More Effective

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Reagents and Kits

      2. 5.1.2 Instruments

      3. 5.1.3 Consumables & Accessories

    2. 5.2 By Type

      1. 5.2.1 Indirect Immunofluorescence

      2. 5.2.2 Direct Immunofluorescence

    3. 5.3 By Application

      1. 5.3.1 Cancer

      2. 5.3.2 Infectious Diseases

      3. 5.3.3 Autoimmune Diseases

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc.

      2. 6.1.2 Inova Diagnostics, Inc.

      3. 6.1.3 Bio-Rad Laboratories, Inc.

      4. 6.1.4 Abcam

      5. 6.1.5 PerkinElmer Inc.

      6. 6.1.6 Merck Millipore

      7. 6.1.7 Cell Signaling Technology

      8. 6.1.8 MEDIPAN GMBH

      9. 6.1.9 Sino Biological

      10. 6.1.10 Danaher Corporation

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immunofluorescence Assay Market market is studied from 2018 - 2026.

The Immunofluorescence Assay Market is growing at a CAGR of 5.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher, Inova Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc. are the major companies operating in Immunofluorescence Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!